These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3413875)

  • 21. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
    Van Echo DA; Markus S; Aisner J; Wiernik PH
    Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].
    Tominaga K; Saijo N; Eguchi K; Shinkai T; Shimizu E
    Gan No Rinsho; 1984 Sep; 30(11):1344-50. PubMed ID: 6094880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lung.
    Rudnick SA; Neijstrom E; Capizzi RL; Delaney D; Kirsch M
    Cancer Treat Rep; 1982 Mar; 66(3):541-4. PubMed ID: 7060040
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast.
    Sternberg CN; Yagoda A; Casper E; Scoppetuolo M; Scher HI
    Anticancer Res; 1985; 5(4):415-7. PubMed ID: 4037737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature.
    Weiselberg L; Budman D; Vinciguerra V; Schulman P; Degnan TJ
    Cancer Clin Trials; 1981; 4(2):195-8. PubMed ID: 7249256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of mitomycin, methotrexate, and vincristine combination chemotherapy in advanced adenocarcinoma of the lung.
    Shah A; Klimo P; Murray N
    Cancer Treat Rep; 1984 Oct; 68(10):1299-300. PubMed ID: 6525603
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
    Bukowski RM; LoBuglio A; McCracken J; Pugh R
    Cancer Treat Rep; 1980; 64(12):1387-8. PubMed ID: 7471126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.
    Dhingra HM; Umsawasdi T; Chiuten DF; Murphy WK; Holoye PY; Spitzer G; Valdivieso M
    Cancer Treat Rep; 1986 May; 70(5):673-4. PubMed ID: 3708617
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II evaluation of bisantrene in patients with renal cell carcinoma.
    Myers JW; Von Hoff DD; Coltman CA; Kuhn JG; Van Echo D; Rivkin S; Pocelinko R
    Cancer Treat Rep; 1982 Oct; 66(10):1869-71. PubMed ID: 7127326
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II evaluation of maytansine in patients with metastatic lung cancer.
    Eagan RT; Creagan ET; Ingle JN; Frytak S; Rubin J
    Cancer Treat Rep; 1978 Oct; 62(10):1577-9. PubMed ID: 709559
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormonal therapy of adenocarcinoma of the kidney].
    Barsel' VA; Volin EM; Parfenova LK; Orlova RS
    Urol Nefrol (Mosk); 1973; 38(1):62-3. PubMed ID: 4693767
    [No Abstract]   [Full Text] [Related]  

  • 33. [Report of experiences with ambulatory cytostatic chemotherapy in germinal testicular tumors and metastasizing renal carcinomas].
    Schulz R; Vogler H
    Z Urol Nephrol; 1981 Jan; 74(1):21-33. PubMed ID: 7195123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma.
    Schneider RJ; Woodcock TM; Yagoda A
    Cancer Treat Rep; 1980 Jan; 64(1):183-5. PubMed ID: 6892892
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of vindesine in adenocarcinoma of the lung.
    Sledge GW; Clark GM; Von Hoff DD
    Cancer Treat Rep; 1984 Mar; 68(3):557-8. PubMed ID: 6704986
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of etoposide for pulmonary metastases from urogenital tract cancer].
    Fujita K; Murayama T; Sayama T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2438-41. PubMed ID: 6497402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.
    Hahn RG; Begg CB; Davis T
    Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
    Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
    Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Phase I clinical study of human leukocytic interferon II for injections].
    Garin AM; Lichinitser MR; Kuznetsov VP; Tiuliandin SA; Rubtsov BI
    Ter Arkh; 1983; 55(8):137-41. PubMed ID: 6415838
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II study on DON in patients with previously treated advanced lung cancer.
    Eagan RT; Frytak S; Nichols WC; Creagan ET; Ingle JN
    Cancer Treat Rep; 1982 Aug; 66(8):1665-6. PubMed ID: 6286122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.